Acute liver failure in a metropolitan area in Germany: A retrospective study (2002-2008)

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 9, 2009, Pages 807-813

  Canbay, Ali ^a   Jochum, C ^a   Bechmann, L P ^a   Festag, S ^a   Gieseler, R K ^a   Yuksel Z ^a   Lutkes P ^a   Saner, F H ^a   Paul, A ^a   Gerken, G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acetaminophen; Body mass index; Cholestasis; Drug toxicity; Epidemiology

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; PARACETAMOL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHOLESTASIS; DRUG INDUCED DISEASE; FEMALE; GERMANY; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; SURVIVAL RATE; URBAN AREA; VIRUS HEPATITIS;

ADULT; COMORBIDITY; DRUG TOXICITY; FEMALE; GERMANY; HEPATITIS; HUMANS; LIVER FAILURE, ACUTE; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; URBAN POPULATION;

EID: 68149157702     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109058     Document Type: Article

References (41)

1. O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81: 148-154
2. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217-226 (Pubitemid 37052447)
3. Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954 (Pubitemid 35440240)
4. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004; 40: 192-197 (Pubitemid 38115821)
5. Wei G, Bergquist A, Broome U et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262: 393-401 (Pubitemid 47246972)
6. Canbay A, Chen SY, Gieseler RK et al. Overweight patients are more susceptible for acute liver failure. Hepatogastroenterology 2005; 52: 1516-1520 (Pubitemid 41391028)
7. Rutherford A, Davern T, Hay JE et al. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol 2006; 4: 1544-1549 (Pubitemid 44883348)
8. Choi WC, Arnaout WC, Villamil FG et al. Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure. Korean J Intern Med 2007; 22: 93-100
9. Yantorno SE, Kremers WK, Ruf AE et al. MELD is superior to King's College and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007; 13: 822-828
10. Taylor RM, Davern T, Munoz S et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 2006; 44: 1589-1597 (Pubitemid 44953664)
11. Pazzi P, Morsiani E, Vilei MT et al. Serum bile acids in patients with liver failure supported with a bioartificial liver. Aliment Pharmacol Ther 2002; 16: 1547-1554 (Pubitemid 34953596)
12. Demetris AJ, Seaberg EC, Wennerberg A et al. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996; 149: 439-448 (Pubitemid 26256332)
13. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-S53
14. Huang W, Ma K, Zhang J et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006; 312: 233-236
15. Geier A, Trautwein C. Bile acids are "homeotrophic" sensors of the functional hepatic capacity and regulate adaptive growth during liver regeneration. Hepatology 2007; 45: 251-253
16. Geier A, Wagner M, Dietrich CG et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 2007; 1773: 283-308 (Pubitemid 46275063)
17. Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176 (Pubitemid 351975541)
18. Bower WA, Johns M, Margolis HS et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102: 2459-2463 (Pubitemid 47631759)
19. Bernal W, Ma Y, Smith HM et al. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47: 664-670 (Pubitemid 47503423)
20. Hadem J, Stiefel P, Bahr MJ et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol 2008; 6: 339-345 (Pubitemid 351318381)
21. Schiodt FV, Atillasoy E, Shakil AO et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34 (Pubitemid 29037351)
22. Koskinas J, Deutsch M, Kountouras D et al. Aetiology and outcome of acute hepatic failure in Greece: experience of two academic hospital centres. Liver Int 2008; 28: 821-827 (Pubitemid 351818644)
23. Escorsell A, Mas A, de la Mata M. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007; 13: 1389-1395 (Pubitemid 47629571)
24. Schimanski CC, Burg J, Mohler M et al. Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-)acute liver failure. J Hepatol 2004; 41: 67-74 (Pubitemid 39005155)
25. Larson AM, Polson J, Fontana RJ et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-1372 (Pubitemid 43260039)
26. Gow PJ, Jones RM, Dobson JL et al. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol 2004; 19: 154-159
27. Larsen FS, Kirkegaard P, Rasmussen A et al. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 1995; 27: 3519-3520 (Pubitemid 26016300)
28. Schmidt LE. Age and paracetamol self-poisoning. Gut 2005; 54: 686-690
29. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002; 36: 659-665 (Pubitemid 34977176)
30. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002; 35: 876-882 (Pubitemid 34258382)
31. Schmidt LE, Dalhoff K. Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol 2002; 53: 535-541 (Pubitemid 34526505)
32. Krahenbuhl S, Brauchli Y, Kummer O et al. Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage. Digestion 2007; 75: 232-237 (Pubitemid 350202474)
33. Bramlage P, Pittrow D, Wittchen HU et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 2004; 17: 904-910 (Pubitemid 39366016)
34. Hach I, Ruhl UE, Klose M et al. Obesity and the risk for mental disorders in a representative German adult sample. Eur J Public Health 2007; 17: 297-305 (Pubitemid 47356287)
35. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231
36. Feldstein A, Canbay A, Guicciardi ME et al. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 2003; 39: 978-983 (Pubitemid 37523769)
37. Court MH, Duan SX, von Moltke LL et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 2001; 299: 998-1006
38. Court MH. Acetaminophen UDP-glucuronosyltransferase in ferrets: species and gender differences, and sequence analysis of ferret UGT1A6. J Vet Pharmacol Ther 2001; 24: 415-422
39. Acuna G, Foernzler D, Leong D et al. Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity. Pharmacogenomics J 2002; 2: 327-334 (Pubitemid 35439475)
40. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000; 108: 567-574
41. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39: 1477-1487 (Pubitemid 38702646)